Evidence of apoptosis in alcoholic cardiomyopathy

Human Pathology

Volumn 37, Issue 8, 2006, Pages 1100-1110

  Fernández Solà, Joaquim ^a   Fatjó, Francesc ^a   Sacanella, Emilio ^a   Estruch, Ramón ^a   Bosch, Xavier ^a   Urbano Márquez, Alvaro ^a   Nicolás, José María ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Alcoholism; Apoptosis; Dilated cardiomyopathy; Hypertension

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC CARDIOMYOPATHY; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EVALUATION; FEMALE; HEART; HEART INJURY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MEASUREMENT; MORPHOMETRICS; NICK END LABELING; ORGAN DONOR; PROTEIN EXPRESSION;

ALCOHOLISM; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARDIOMYOPATHY, ALCOHOLIC; DNA FRAGMENTATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33746065619     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.03.022     Document Type: Article

References (47)

1. Urbano-Márquez A., Estruch R., Navarro-López F., Grau J.M., Mont L., and Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320 (1989) 409-411
2. Moushmoush B., and Ali-Mansour P. Alcohol and the heart: the long-term effects of alcohol on the cardiovascular system. Arch Intern Med 151 (1991) 36-42
3. Urbano-Márquez A., and Fernández-Solà J. The effects of alcohol on skeletal and cardiac muscle. Muscle Nerve 30 (2004) 689-707
4. Piano M. Alcoholic cardiomyopathy: incidence, clinical characteristics and pathophysiology. Chest 121 (2002) 1638-1650
5. Fernández-Solà J., Nicolás J.M., Fatjó F., Paré J.C., Sacanella E., and Estruch R. Diastolic impairment in alcoholics. Alcohol Clin Exp Res 24 (2000) 1830-1835
6. Nicolás J.M., Fernández-Solà J., Estruch R., Paré J.C., Urbano-Márquez A., and Rubin E. The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 136 (2002) 192-200
7. Danziger R.S., Sakai M., Capogrossi M.C., Spurgeon H.A., Hansford R.G., and Lakata E.G. Ethanol acutely and reversibly suppresses excitation-contraction coupling in cardiac myocytes. Circ Res 68 (1991) 1660-1668
8. Preedy V.R., Patel V.B., Why H.J.F., Corbett J.M., Dunn M.J., and Richarson P.J. Alcohol and heart: biochemical alterations. Cardiovasc Res 31 (1996) 139-147
9. Haunstetter A., and Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circulation 82 (1998) 1111-1129
10. Saraste A., Pulkki K., Kallajoki M., et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29 (1999) 292
11. Regula K.M., and Kirshembaum L.A. Apoptosis of ventricular myocytes; a means to an end. J Mol Cell Cardiol 38 (2005) 3-13
12. Sobel L.C., Maisto S.A., Sobell M.B., and Cooper A.M. Reliability of alcohol abusers' self-reports of drinking behaviour. Behav Res Ther 17 (1979) 157-160
13. Fernández-Solà J., Estruch R., Grau J.M., Pare J.C., Urbano-Márquez A., and Rubin E. The relation of alcoholic myopathy to cardiomyopathy. Ann Intern Med 120 (1994) 529-536
14. Goldman L., Hashimoto B., Cook E.F., and Loscalzo A. Comparative reproducibility and validity of assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64 (1981) 1227-1234
15. Gottdiener J.S., Berdnarz J., Devereux R., et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17 (2004) 1086-1119
16. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335 (1996) 1182-1189
17. Paul M. Apoptosis in cardiac disease: from basics to clinics-an editorial commentary. Symposium: Programmed Cell Death-Clinical Reality and Therapeutic Strategies. Cardiovasc Drugs Ther 15 (2001) 553-554
18. Sandri M., Carraro U., Podhorska-Okolow M., et al. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett 373 (1995) 291-295
19. Hughes S.E. Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart: fact or epiphenomenon. J Pathol 201 (2003) 181-186
20. Koda M., Takemura G., Kanoh M., et al. Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure. J Pathol 199 (2003) 229-236
21. Kanoh M., Takemura G., Misao J., et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 99 (1999) 2757-2764
22. Sarastre A. Morphologic criteria and detection of apoptosis. Herz 24 (1999) 189-195
23. Turillazi E., Baroldi G., Silver M.D., Parolini M., Pomara C., and Fineschi V. A systematic study of a myocardial lesion: colliquative myocytolysis. Int J Cardiol 104 (2005) 152-157
24. Neuss M., Crow M.T., Chelsey A., and Lakatta E.G. Apoptosis in cardiac disease: what is it-how does it occur?. Cardiovasc Drugs Ther 15 (2001) 509-525
25. Sabahh H.N., and Sharov V.G. Apoptosis in heart failure. Prog Cardiovasc Dis 40 (1998) 549-562
26. Van Empel V.P.M., and De Windt L.J. Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc Res 63 (2004) 487-499
27. Molina P., McClain C., Valla D., et al. Molecular pathology and clinical aspects of alcohol-induced tissue injury. Alcohol Clin Exp Dis 26 (2002) 120-128
28. Jänkälä H., Eriksson P., Eklund K.E., Härkönen M., and Mäkin T. Combined calcium carbimide and ethanol treatment induces high blood acetaldehyde levels, myocardial apoptosis and altered expression of apoptosis-regulating genes in rat. Alcohol Alcohol 37 (2002) 222-228
29. Fernández-Solà J., Nicolás J.M., Fatjó F., et al. Evidence of apoptosis in chronic alcoholic skeletal myopathy. Hum Pathol 34 (2003) 1247-1252
30. Anversa P., and Nadal-Guinard B. Myocyte renewal and ventricular remodeling. Nature 415 (2002) 240-243
31. Yussman M.G., Toyokawa T., Odley A., et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8 (2002) 725-730
32. de Carcalho Frim C., Soufen H.N., Koihe M.K., and Pereira V. The long-term outcome of patients with hypertensive cardiomyopathy. J Hum Hypertens 19 (2005) 393-400
33. Hajnoczk Y.G., Buzas C.J., Pacher P., Hoeck J.B., and Rubin E. Alcohol and mitochondria in cardiac apoptosis: mechanisms and visualization. Alcohol Clin Exp Res 29 (2005) 693-701
34. Gonzalez A., Fortuno M.A., Querejeta R., et al. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 59 (2003) 549-562
35. Nadal-Guinard B., Kajstura J., Anversa P., and Leri A. Myocyte deaths, growth and regeneration in cardiac hypertrophy and failure. Circ Res 92 (2003) 139-150
36. Leri A., Kajstura J., and Anversa P. Myocyte proliferation and ventricular remodeling. J Cardiac Fail 8 (2002) S518-S525
37. Anversa P., Sussman M., and Bolli R. Molecular genetic advances in cardiovascular medicine. Circulation 109 (2004) 2832-2838
38. Dong Q., Xiao Y., Joshi-Barnes S., McClain C.J., and Barve S.S. Ethanol enhances activation-induced caspase-3 dependent cell death in T lymphocytes. Alcohol Clin Exp Res 26 (2002) 363-370
39. Aroor A.R., and Shukla S.D. MAP kinase signaling in diverse effects of ethanol. Life Sci 74 (2004) 2339-2364
40. Chen D.B., Wang L., and Wang P.H. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes. Life Sci 67 (2000) 1683-1693
41. Fernández-Solà J., Nicolas J.M., Oriola J., et al. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann Intern Med 137 (2002) 321-326
42. Hetts S.W. To die or not to die: an overview of apoptosis and its role in disease. JAMA 279 (1998) 511-532
43. Condorelli G., Morisco C., Stassi G., et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left-ventricular adaptations to chronic pressure overload in the rat. Circulation (1999) 3071-3078
44. Gustafsson A.B., and Gottlieb R.A. Mechanisms of apoptosis in the heart. J Clin Immunol 23 (2003) 447-459
45. Berneker O.Y., Huq F., Heist E.K., Podesser B.K., and Hajjar R.J. Apoptosis in heart failure and the senescent heart. Cardiovasc Toxicol 3 (2003) 183-190
46. Feuerstein G.Z. Apoptosis: new opportunities for novel therapeutics for heart diseases. Cardiovasc Drugs Ther 15 (2001) 547-551
47. Webster K., and Bishopric N. Apoptosis inhibitors for heart disease. Circulation 108 (2003) 2954